Imperial College Healthcare NHS Trust
imperial.nhs.ukLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
79
Active
10
Phase 3
1
Total enrollment
158,362
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Fenfluramine Hydrochloride | — | — | — | — | — | 1 | |
| Salmonella Typhimurium | — | — | — | — | — | 1 |
Next readouts
- 2026-02-28
- 2028-07
Top conditions
- Covid193
- Blood Pressure3
- Anesthesia2
- Tuberculosis2
- Peripheral Arterial Disease2
- Peripheral Artery Disease2
- Lung Cancer2
- Hypoactive Sexual Desire Disorder2
Frequently asked questions about Imperial College Healthcare NHS Trust
- How many clinical trials does Imperial College Healthcare NHS Trust have on ClinicalTrials.gov?
- Imperial College Healthcare NHS Trust is listed as the lead sponsor on 79 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Imperial College Healthcare NHS Trust's trials are in Phase 3?
- 1 of Imperial College Healthcare NHS Trust's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Imperial College Healthcare NHS Trust focus on?
- Imperial College Healthcare NHS Trust's most-studied conditions on ClinicalTrials.gov are Covid19, Blood Pressure, Anesthesia, Tuberculosis, Peripheral Arterial Disease.
- When are Imperial College Healthcare NHS Trust's next clinical trial readouts?
- Imperial College Healthcare NHS Trust has 2 upcoming primary-completion readouts tracked here; the soonest is “Challenge Non-Typhoidal Salmonella (CHANTS) Study”, expected around 2026-02-28.